Aprogen Biologics Inc. (KRX: 003060)
South Korea flag South Korea · Delayed Price · Currency is KRW
703.00
-32.00 (-4.35%)
Dec 19, 2024, 3:30 PM KST

Aprogen Biologics Company Description

Aprogen Biologics Inc. manufactures and sells pharmaceutical products primarily in South Korea.

It offers approximately 200 types of medicines, including ethical and over the counter drugs. The company offers its drugs for transfusion, digestive system, osteoarthritis, skeletal muscle relaxants, NSAIDs, osteoporosis, circulatory system, endocrine, respiratory system, urinary system, depilatory, antihistamines and antiallergics, obesity, brain function, neurologics, and male pattern hair loss.

It also provides anti-biotic, anti-fungal, anti-viral, anti-ulcerant, anti-epliepsy products; external agents; anti-cancer drugs; amino-acid nutrient transfusion agents; and cosmetics.

Aprogen Biologics Inc. was founded in 1960 and is headquartered in Seongnam-si, South Korea.

Aprogen Biologics Inc.
Country South Korea
Founded 1960
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 377
CEO Jeong-Chool Kim

Contact Details

Address:
Halla Sigma Valley 442-2
Seongnam-si
South Korea
Phone 82 2 561 4011
Website en.aprogen-pharm.com

Stock Details

Ticker Symbol 003060
Exchange Korea Stock Exchange
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7003060001
SIC Code 2834

Key Executives

Name Position
Jeong-Chool Kim Chief Executive Officer
Jung-Chul Kim President